EU Clinical Trial Information System (CTIS)

Brand Logo

Brand Logo Light

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

This is a randomized, open-label, crossover study to examine the bioavailability of pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes mellitus using insulin.

Evaluation of the Bioavailability of Pramlintide

Link to study results on ClinicalStudyResults.org

New Orleans Center for Clinical Research

Orlando Clinical Research Center

DaVita Clinical Research

CEDRA Clinical Research, LLC

To determine the effect of various anatomical injection sites and varying
needle lengths upon the absolute bioavailability of pramlintide when
injected subcutaneously (SC) in non-obese and obese subjects with type 1
and type 2 diabetes mellitus using insulin.

To assess the safety and tolerability of pramlintide when injected SC at
various anatomical sites and with various needle lengths in non-obese and
obese subjects with type 1 and type 2 diabetes mellitus using insulin

Evaluation of the Bioavailability of Pramlintide

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Documents available

Link to study results on ClinicalStudyResults.org

Trial Results Summaries

Contacts

Contact